Global Anti-inflammatory Therapeutics Competitive Landscape Professional Research Report 2024
Description
Global Anti-inflammatory Therapeutics Competitive Landscape Professional Research Report 2024
Research Summary
Anti-inflammatory therapeutics refer to drugs or drugs that are used to reduce inflammation and swelling in the body. These drugs work by targeting the immune system and reducing the production of inflammatory molecules, such as cytokines and prostaglandins, which cause inflammation and pain. Anti-inflammatory therapeutics are commonly used to treat a wide variety of conditions, including arthritis, asthma, inflammatory bowel disease, and skin conditions like psoriasis and eczema. They can be taken orally, topically, or by injection, and are available in a variety of forms including over-the-counter medications, prescription drugs, and biologics.
According to DIResearch's in-depth investigation and research, the global Anti-inflammatory Therapeutics market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.
The major global manufacturers of Anti-inflammatory Therapeutics include AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Sanofi, Merck, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Anti-inflammatory Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Anti-inflammatory Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Anti-inflammatory Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Anti-inflammatory Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Anti-inflammatory Therapeutics Include:
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sanofi
Merck
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Anti-inflammatory Therapeutics Product Segment Include:
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Anti-inflammatory Therapeutics Product Application Include:
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Anti-inflammatory Therapeutics Industry PESTEL Analysis
Chapter 3: Global Anti-inflammatory Therapeutics Industry Porter’s Five Forces Analysis
Chapter 4: Global Anti-inflammatory Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Anti-inflammatory Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Anti-inflammatory Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Anti-inflammatory Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Anti-inflammatory Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Anti-inflammatory Therapeutics Product by Type
- 1.2.1 Global Anti-inflammatory Therapeutics Market Size by Type, 2023 VS 2024 VS 2030
- 1.2.2 Anti-inflammatory Biologics
- 1.2.3 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
- 1.2.4 Corticosteroids
- 1.2.5 Others
- 1.3 Anti-inflammatory Therapeutics Product by Application
- 1.3.1 Global Anti-inflammatory Therapeutics Market Size by Application, 2023 VS 2024 VS 2030
- 1.3.2 Arthritis
- 1.3.3 Respiratory Diseases
- 1.3.4 Dermatology
- 1.3.5 Gastroenterology
- 1.3.6 Others
- 1.4 Global Anti-inflammatory Therapeutics Market Revenue Analysis (2019-2030)
- 1.5 Anti-inflammatory Therapeutics Market Development Status and Trends
- 1.5.1 Anti-inflammatory Therapeutics Industry Development Status Analysis
- 1.5.2 Anti-inflammatory Therapeutics Industry Development Trends Analysis
- 2 Anti-inflammatory Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Anti-inflammatory Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Anti-inflammatory Therapeutics Market Analysis by Regions
- 4.1 Anti-inflammatory Therapeutics Overall Market: 2023 VS 2024 VS 2030
- 4.2 Global Anti-inflammatory Therapeutics Revenue and Forecast Analysis (2019-2030)
- 4.2.1 Global Anti-inflammatory Therapeutics Revenue and Market Share by Region (2019-2024)
- 4.2.2 Global Anti-inflammatory Therapeutics Revenue Forecast by Region (2025-2030)
- 5 Global Anti-inflammatory Therapeutics Market Size by Type and Application
- 5.1 Global Anti-inflammatory Therapeutics Market Size by Type
- 5.2 Global Anti-inflammatory Therapeutics Market Size by Application
- 6 North America
- 6.1 North America Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2019-2030)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Anti-inflammatory Therapeutics Market Size by Type
- 6.4 North America Anti-inflammatory Therapeutics Market Size by Application
- 6.5 North America Anti-inflammatory Therapeutics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2019-2030)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Anti-inflammatory Therapeutics Market Size by Type
- 7.4 Europe Anti-inflammatory Therapeutics Market Size by Application
- 7.5 Europe Anti-inflammatory Therapeutics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2019-2030)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Anti-inflammatory Therapeutics Market Size by Type
- 8.4 China Anti-inflammatory Therapeutics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2019-2030)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Anti-inflammatory Therapeutics Market Size by Type
- 9.4 APAC (excl. China) Anti-inflammatory Therapeutics Market Size by Application
- 9.5 APAC (excl. China) Anti-inflammatory Therapeutics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Indonesia
- 9.5.6 Vietnam
- 9.5.7 Malaysia
- 9.5.8 Thailand
- 10 Latin America
- 10.1 Latin America Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2019-2030)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Anti-inflammatory Therapeutics Market Size by Type
- 10.4 Latin America Anti-inflammatory Therapeutics Market Size by Application
- 10.5 Latin America Anti-inflammatory Therapeutics Market Size by Country
- 10.5.1 Mecixo
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Anti-inflammatory Therapeutics Market Size and Growth Rate Analysis (2019-2030)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Type
- 11.4 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Application
- 11.5 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Market Competition by Manufacturers
- 12.1 Global Anti-inflammatory Therapeutics Market Revenue by Key Manufacturers (2020-2024)
- 12.2 Anti-inflammatory Therapeutics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Anti-inflammatory Therapeutics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 AbbVie
- 13.1.1 AbbVie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 AbbVie Anti-inflammatory Therapeutics Product Portfolio
- 13.1.3 AbbVie Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.2 Johnson & Johnson
- 13.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Johnson & Johnson Anti-inflammatory Therapeutics Product Portfolio
- 13.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.3 Amgen Inc
- 13.3.1 Amgen Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Amgen Inc Anti-inflammatory Therapeutics Product Portfolio
- 13.3.3 Amgen Inc Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.4 AstraZeneca PLC
- 13.4.1 AstraZeneca PLC Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 AstraZeneca PLC Anti-inflammatory Therapeutics Product Portfolio
- 13.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.5 Pfizer, Inc
- 13.5.1 Pfizer, Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Pfizer, Inc Anti-inflammatory Therapeutics Product Portfolio
- 13.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.6 Novartis
- 13.6.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Novartis Anti-inflammatory Therapeutics Product Portfolio
- 13.6.3 Novartis Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.7 Roche
- 13.7.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Roche Anti-inflammatory Therapeutics Product Portfolio
- 13.7.3 Roche Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.8 Sanofi
- 13.8.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Sanofi Anti-inflammatory Therapeutics Product Portfolio
- 13.8.3 Sanofi Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.9 Merck
- 13.9.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Merck Anti-inflammatory Therapeutics Product Portfolio
- 13.9.3 Merck Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.10 GlaxoSmithKline
- 13.10.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 GlaxoSmithKline Anti-inflammatory Therapeutics Product Portfolio
- 13.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.11 Sun Pharmaceutical Industries Ltd
- 13.11.1 Sun Pharmaceutical Industries Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product Portfolio
- 13.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 13.12 TEVA
- 13.12.1 TEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 TEVA Anti-inflammatory Therapeutics Product Portfolio
- 13.12.3 TEVA Anti-inflammatory Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)
- 14 Industry Chain Analysis
- 14.1 Anti-inflammatory Therapeutics Industry Chain Analysis
- 14.2 Anti-inflammatory Therapeutics Industry Raw Material and Suppliers Analysis
- 14.2.1 Upstream Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Anti-inflammatory Therapeutics Typical Downstream Customers
- 14.4 Anti-inflammatory Therapeutics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
